{
    "clinical_study": {
        "@rank": "105966", 
        "arm_group": [
            {
                "arm_group_label": "Dose adaptation", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Fixed dose", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will compare the incidence of acute clinical or subclinical rejection between\n      immunosuppression with CellCept at a starting dose of 3mg po daily with therapeutic drug\n      monitoring and standard immunosuppression with CellCept and a fixed dose of 2g po daily, in\n      kidney transplant recipients receiving induction by anti-IRL2, cyclosporine therapy, and\n      early discontinuation of steroids. Patients will be randomized to one of the two treatment\n      arms. The anticipated time on study treatment is 52 weeks."
        }, 
        "brief_title": "OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.", 
        "completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "condition": "Kidney Transplantation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients, aged 18-75 years of age;\n\n          -  in receipt of first donor kidney;\n\n          -  eligible to receive immunosuppressive treatment comprising IRL2, CellCept,\n             cyclosporine and steroids;\n\n          -  eligible to receive oral treatment from the first day post-transplantation.\n\n        Exclusion Criteria:\n\n          -  patients receiving a second or subsequent kidney transplant, or multi-organ\n             transplant;\n\n          -  history of malignancy in the last 5 years (except successfully treated squamous cell\n             or basal cell cancer and cervical cancer in situ);\n\n          -  patients with active hepatitis B and/or hepatitis C, or HIV infection."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "263", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02005562", 
            "org_study_id": "ML19912"
        }, 
        "intervention": [
            {
                "arm_group_label": "Dose adaptation", 
                "description": "3 g/day from D0 adapted according to the simplified AUC (adaptation by Bayesian method) at Weeks 2, 6 , 12 26 and 52 to obtain AUC0-12 of 50 mg.h/L", 
                "intervention_name": "mycophenolate mofetil [CellCept]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Fixed dose", 
                "description": "2 g/day from D0 with clinical adaptation if necessary. No interruption for more than 14 days from D0 to Week 52", 
                "intervention_name": "mycophenolate mofetil [CellCept]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Dose adaptation", 
                    "Fixed dose"
                ], 
                "description": "iv according to the center's usual practice", 
                "intervention_name": "anti-IRL2", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Dose adaptation", 
                    "Fixed dose"
                ], 
                "description": "500 mg iv before or after transplantation, followed by 0.5 mg/kg orally daily Days 1 to 7", 
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Dose adaptation", 
                    "Fixed dose"
                ], 
                "description": "Introduced during the first 72 hours post-transplantation, adapted to C 2: D0 to Week 4: C2= 100-1500 ng/ml, Weeks 4 to 12: C2 = 800-1200 ng/ml, Weeks 12-52: C2 = 500-800 ng/ml", 
                "intervention_name": "cyclosporine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclosporins", 
                "Cyclosporine", 
                "Mycophenolic Acid", 
                "Mycophenolate mofetil", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-ferrand", 
                        "country": "France", 
                        "zip": "63000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France", 
                        "zip": "94010"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Tronche", 
                        "country": "France", 
                        "zip": "38700"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin-bicetre", 
                        "country": "France", 
                        "zip": "94275"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44035"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06002"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75970"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75475"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75018"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75743"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86021"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35033"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salouel", 
                        "country": "France", 
                        "zip": "80480"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suresnes", 
                        "country": "France", 
                        "zip": "92151"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31054"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre-les-nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Study Comparing the Incidence of Acute Clinical or Subclinical Rejection With Two Dosing Regimens of CellCept in de Novo Renal Transplant Recipients Receiving Induction, Cyclosporine and Brief Steroid Therapy", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Agence Nationale de Securite du Medicament"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of biopsy-proven acute rejections before week 12, and number of subclinical rejections on systematic biopsy at week 12", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02005562"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in serum creatinine", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Week 52"
            }, 
            {
                "measure": "Change in creatinine clearance", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Week 52"
            }, 
            {
                "measure": "Patient and graft survival", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }, 
            {
                "measure": "Number of biopsy proven acute rejections from week 12 and 52,", 
                "safety_issue": "No", 
                "time_frame": "from Week 12 to Week 52"
            }, 
            {
                "measure": "Histological evaluation of graft during acute rejection or on systematic biopsies", 
                "safety_issue": "No", 
                "time_frame": "Weeks 12 and 52"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2006", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}